Advertisement

Topics

Bristol-Myers Squibb To Acquire IFM Therapeutics

16:35 EDT 3 Aug 2017 | FinanzNachrichten

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) and IFM Therapeutics announced the companies have signed an agreement under which Bristol-Myers Squibb will acquire all of the outstand...

Original Article: Bristol-Myers Squibb To Acquire IFM Therapeutics

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb To Acquire IFM Therapeutics"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...